Medication-related osteonecrosis of the jaw after dental clearance: Prevalence in an oncology center

Medication-related osteonecrosis of the jaw after dental clearance: Prevalence in an oncology center

Objective: Medication-related osteonecrosis of the jaw (MRONJ), a complication of bisphosphonate therapy, has significant morbidity. This study aimed to determine the prevalence of MRONJ and compare its risks among patients who received antiresorptive or antiangiogenic therapy in King Fahad Medical...

Full description

Bibliographic Details
Main Authors:	Saad Hajeri, BDS, Yasir Alturkistany, BDS, MBA
Format:	Article
Language:	English
Published:	Elsevier 2022-09-01
Series:	Saudi Dental Journal
Subjects:	MRONJ osteonecrosis of the jaw alendronate oral bisphosphonates denosumab
Online Access:	http://www.sciencedirect.com/science/article/pii/S101390522200075X

Similar Items

A retrospective case series on bisphosphonate related osteonecrosis of the jaw in 20 cats
by: Suzanna L. Hatunen, et al.
Published: (2024-08-01)

A Multi-Center Observation Study on Medication-Related Osteonecrosis of the Jaw (MRONJ) in Patients with Osteoporosis, and Other Non-Malignant Bone Diseases, in Northwestern Italy over 16 Years
by: Dora Karimi, et al.
Published: (2024-09-01)

Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ)
by: Sven Otto, et al.
Published: (2021-05-01)

Medication-Related Osteonecrosis of the Jaw in Dental Practice: A Retrospective Analysis of Data from the Milan Cohort
by: Cristina Mirelli, et al.
Published: (2022-05-01)

Current Controversies on the Pathogenesis of Medication-Related Osteonecrosis of the Jaw
by: Winnie Zee Man Wat
Published: (2016-10-01)

Osteonecrosis of the Jaw (ONJ) in Osteoporosis Patients: Report of Delayed Diagnosis of a Multisite Case and Commentary about Risks Coming from a Restricted ONJ Definition
by: Mario Migliario, et al.
Published: (2017-03-01)

Awareness among patient at risk of developing Medication Related Osteonecrosis of the Jaw (MRONJ) – A primary prevention strategy
by: Abdulrhman Al Abdullateef, et al.
Published: (2020-06-01)

Medication‐related osteonecrosis of the jaw and successful implant treatment in a patient on high‐dose antiresorptive medication: A case report
by: Camilla Ottesen, et al.
Published: (2022-10-01)

<i>ONJ (MRONJ) Update 2021</i>—Osteonecrosis of Jaw Related to Bisphosphonates and Other Drugs—Prevention, Diagnosis, Pharmacovigilance, Treatment: A 2021 Web Event
by: Vittorio Fusco, et al.
Published: (2022-04-01)

Case Report: single low-dose of denosumab as a trigger of MRONJ development in a patient with osteoporosis after bisphosphonate therapy
by: Dávid Száraz, et al.
Published: (2024-12-01)

Medication-Related Osteonecrosis of the Jaws (MRONJ): Etiological Update
by: Gianluca Tenore, et al.
Published: (2014-12-01)

Autologous Platelet-Rich Fibrin (PRF) as an Adjunct in the Management of Osteoradionecrosis and Medication-Related Osteonecrosis of Jaws. Case Series in A Single Centre
by: Benjie Law, et al.
Published: (2021-04-01)

Case Report: Development of medication-related osteonecrosis of the jaw in a patient on long-term infliximab therapy
by: Derek Oryniak, et al.
Published: (2024-07-01)

Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published on Lancet Oncology
by: Vittorio Fusco, et al.
Published: (2018-09-01)

Osteonecrosis of the jaw after dental implant placement. A case report
by: J.L. Calvo-Guirado, et al.
Published: (2014-03-01)

Comparison of the Effectiveness of Conservative and Surgical Treatment of Medication-Related Osteonecrosis of the Jaw: a Systematic Review
by: Rial Seluki, et al.
Published: (2023-12-01)

Implications in dental treatment during the use of antiresorptive drugs - a literature review
by: Aleksandra Dziewulska, et al.
Published: (2024-10-01)

Chinese expert consensus on the diagnosis and clinical management of medication-related osteonecrosis of the jaw
by: Han-Jin Ruan, et al.
Published: (2024-12-01)

Delayed Diagnosis of Osteonecrosis of the Jaw (ONJ) Associated with Bevacizumab Therapy in Colorectal Cancer Patients: Report of Two Cases
by: Francesco Erovigni, et al.
Published: (2016-10-01)

DENOSUMAB-RELATED OSTEONECROSIS OF THE JAWS: A CASE REPORT
by: Milena Petkova, et al.
Published: (2017-03-01)

Medication-Related Osteonecrosis of the Jaw: A Systematic Review of Case Reports and Case Series
by: Filipa Frutuoso, et al.
Published: (2024-09-01)

Alendronate-Induced Osteonecrosis of the Jaw in an Elderly Female
by: Bi-Wei Jan, et al.
Published: (2012-06-01)

Plasma Therapy for Medication-Related Osteonecrosis of the Jaws- A Case Report
by: Maryam Jalili Sadrabad, et al.
Published: (2023-07-01)

Oral Complications in Cancer Patients–Medication-Related Osteonecrosis of the Jaw (MRONJ)
by: Cesar Augusto Migliorati
Published: (2022-04-01)

Medication-Related Osteonecrosis of the Jaw—A Continuing Issue
by: Krzysztof Wróbel, et al.
Published: (2021-08-01)

Bisphosphonate-associated osteonecrosis of the jaws
by: Pankaj Agarwal, et al.
Published: (2012-01-01)

Medication-related osteonecrosis of the jaw: Prosthodontic considerations
by: Islam E. Ali, et al.
Published: (2022-11-01)

Awareness, perceptions and attitudes toward medication-related osteonecrosis of the jaw among physicians who treat osteoporosis
by: Suad Aljohani
Published: (2023-09-01)

The Use of Photodynamic Therapy on Medication-Related Osteonecrosis of the Jaws: Animal Study
by: Karapinar Gökay, et al.
Published: (2021-03-01)

A Systematic Review of Laser Photobiomodulation Dosimetry and Treatment Protocols in the Management of Medications-Related Osteonecrosis of the Jaws: A Rationalised Consensus for Future Randomised Controlled Clinical Trials
by: Reem Hanna, et al.
Published: (2024-07-01)

Bisphosphonate-Related Osteonecrosis of the Jaws. A Severe Side Effect of Bisphosphonate Therapy
by: Zuzana Janovská
Published: (2012-01-01)

Development of Osteonecrosis of the Jaw in a Patient Receiving Oral Bisphosphonates for Osteoporosis: A Case Report
by: Sina Esmaeilzadeh, et al.
Published: (2014-08-01)

Surgical management in patients with bisphosphonate-related osteonecrosis of the jaw: four cases
by: Emre Dikicier, et al.
Published: (2014-12-01)

Incidence of antiresorptive agent-related osteonecrosis of the jaw: A multicenter retrospective epidemiological study in Hyogo Prefecture, Japan
by: Masanori Nashi, et al.
Published: (2023-07-01)

Medication-related osteonecrosis of the jaw (MRONJ) and eNOS Polymorphisms in multiple myeloma patients: a single center experience
by: Betul Taş Ozyurtseven, et al.
Published: (2021-05-01)

MRONJ and VIT D insufficiency
by: Gholamreza Shirani, et al.
Published: (2021-07-01)

Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review
by: Mampei Kawahara, et al.
Published: (2021-05-01)

Characteristics of patients with osteonecrosis of the jaw with oral versus intravenous bisphosphonate treatment
by: Seung-Hun Lee, et al.
Published: (2021-07-01)

The progress of medication-related osteonecrosis of the jaw with conservative initial treatment: A 12-year retrospective study of 129 patients
by: Nobuyuki Kaibuchi, et al.
Published: (2021-06-01)

The Influence of Vitamin D Levels and Supplementation on the Treatment of Patients Affected by MRONJ
by: Filip Michalak, et al.
Published: (2025-01-01)